Stuthi Perimbeti
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Zanzalintinib Efficacy Post Pluvicto® in Chemotherapy Naïve Metastatic Castration Resistant Prostate Cancer (NCT07623460) | Stuthi Perimbeti | 2026-09-01 |
Track Stuthi Perimbeti automatically
Every clearance here is in the API, with alerts when new ones post.